Disease | dry eye syndrome |
Phenotype | C0015397|ocular disease |
Sentences | 1 |
PubMedID- 21219997 | In conclusion, these results demonstrate that mpeg-hexpla micelles are promising drug carriers for ocular diseases involving the activation of cytokines, such as dry eye syndrome and autoimmune uveitis, or for the prevention of corneal graft rejection. |
Page: 1